Policy
European Journal of Human Genetics (2006) 14, 588–645. doi:10.1038/sj.ejhg.5201598
The interface between assisted reproductive technologies and genetics: technical, social, ethical and legal issues
Sirpa Soini1,2, Dolores Ibarreta†,3, Violetta Anastasiadou4, Ségolène Aymé5, Suzanne Braga6, Martina Cornel7, Domenico A Coviello8, Gerry Evers-Kiebooms9, Joep Geraedts10, Luca Gianaroli11, Joyce Harper12, György Kosztolanyi13, Kersti Lundin14, Emilio Rodrigues-Cerezo†,3, Karen Sermon15, Jorge Sequeiros16, Lisbeth Tranebjaerg17 and Helena Kääriäinen18 on behalf of ESHG and ESHRE1
- 1Department of Medical Genetics, University of Turku, Turku, Finland
- 2Faculty of Law, Medical and Biolaw, University of Helsinki, Helsinki, Finland
- 3European Commission's Joint Research Centre (Institute of Prospective Technological Studies), Seville, Spain
- 4Archbishop Hospital and Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus
- 5INSERM SC11, Paris, France
- 6SGMG/SSGM, Bern, Switzerland
- 7VU University Medical Centre, Amsterdam, The Netherlands
- 8Laboratorio di Genetica Medica, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Milano, Italy
- 9Psychosocial Genetics Unit, Department of Human Genetics, University of Leuven, Leuven, Belgium
- 10Department of Clinical Genetics, University Hospital Maastricht, Maastricht, The Netherlands
- 11SISMeR, Centre for Reproductive Medicine, Bologna, Italy
- 12UCL Centre for PGD, London, UK
- 13Department of Medical Genetics, University of Pécs, Pécs, Hungary
- 14SU/Sahlgrenska, Göteborg, Sweden
- 15Centre for Medical Genetics, Dutch-speaking Brussels Free University (Vrije Universiteit Brussel, VUB), Brussels, Belgium
- 16Department of Human Genetics, University of Porto, Porto, Portugal
- 17Department of Audiology, H:S Bispebjerg Hospital and Wilhem Johannsen Centre of Functional Genomics, University of Copenhagen, Copenhagen, Denmark
- 18Department of Medical Genetics, University of Turku, Turku, Finland
Correspondence: Professor H Kääriäinen, Department of Medical Genetics, University of Turku, Kiinamyllykatu 10, FIN-20520 Turku, Finland. E-mail: hkaaria@utu.fi
†Disclaimer: The views expressed in this study do not necessarily reflect those of the European Commission (EC).
Abstract
The interface between assisted reproductive technologies (ART) and genetics comprises several sensitive and important issues that affect infertile couples, families with severe genetic diseases, potential children, professionals in ART and genetics, health care, researchers and the society in general. Genetic causes have a considerable involvement in infertility. Genetic conditions may also be transmitted to the offspring and hence create transgenerational infertility or other serious health problems. Several studies also suggest a slightly elevated risk of birth defects in children born following ART. Preimplantation genetic diagnosis (PGD) has become widely practiced throughout the world for various medical indications, but its limits are being debated. The attitudes towards ART and PGD vary substantially within Europe. The purpose of the present paper was to outline a framework for development of guidelines to be issued jointly by European Society of Human Genetics and European Society of Human Reproduction and Embryology for the interface between genetics and ART. Technical, social, ethical and legal issues of ART and genetics will be reviewed.
Keywords:
assisted reproductive technology, birth defects, counselling, genetic diseases, infertility, preimplantation genetic diagnosis
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Widening perspectives of intracytoplasmic sperm injection
Nature Medicine News and Views (01 Apr 1999)
Nature Genetics News and Views (01 Nov 2000)

